James Song, MD

home / authors / james-song-md

James Song, MD

Director of Clinical Research

Frontier Dermatology

Mills Creek, WA

Articles

New Topical Agents for Treatment of Plaque Psoriasis

James Song, MD;Kimberly Gutowsky Baker, FNP-C

February 29th 2024

This publication was developed independently by MJH Life Sciences Global Medical Affairs. Support for the thought leaders meeting and the publication was provided by Arcutis Biotherapeutics, Inc; The Bristol Myers Squibb Company; Janssen Global Services, LLC; and UCB, Inc.

Beyond Skin Deep: Validating and Transforming SD Patient Care

Linda Stein Gold, MD;Neal Bhatia, MD;James Song, MD;Adelaide A. Hebert, MD;Shawn Kwatra, MD

December 14th 2023

Dermatologists end their discussion on seborrheic dermatitis (SD), highlighting key takeaways for patients and clinicians on managing this condition.

Silently Struggling: Discussing the Unseen Burdens of SD

Linda Stein Gold, MD;James Song, MD;Shawn Kwatra, MD;Neal Bhatia, MD;Adelaide A. Hebert, MD

December 14th 2023

Experts discuss the profound impact of seborrheic dermatitis on a patients' well-being, examining the common misconceptions, diagnostic delays, and societal judgments that hinder effective management and necessitate enhanced clinical outreach and patient education.

Emerging Therapies in Seborrheic Dermatitis

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

December 14th 2023

Dermatologists discuss the realm of emerging therapies for seborrheic dermatitis (SD), emphasizing the importance of both breakthrough and failed trials, while highlighting the need for scientific rigor and patient-reported outcomes.

Optimizing and Expediting Care: A Novel Treatment for SD

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

December 7th 2023

Experts reflect on the transformative shift in seborrheic dermatitis treatment, offering effective and time-efficient solutions to identify the disease and educate patients about it.

Managing Seborrheic Dermatitis Across All Skin Types

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

December 7th 2023

Dermatologists discuss clinical considerations when treating seborrheic dermatitis across diverse skin types, addressing common symptoms, concerns, and overall efficacy.

Simplifying Treatment Regimens for Patients With SD

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 30th 2023

Experts explore the challenges of multi-product topical treatment algorithms for seborrheic dermatitis (SD) and the value of once-a-day solutions in fostering adherence, improved quality of life, and overall better outcomes.

The Safety and Efficacy of Novel SD Treatment

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 30th 2023

Dermatologists discuss the safety and efficacy of roflumilast for seborrheic dermatitis (SD), highlighting its tolerability across backgrounds and age groups, safety in pediatric care, and the unmet need it fulfills.

Topical Foam: A Breakthrough in SD Treatment

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 27th 2023

Dermatologists discuss a groundbreaking agent, roflumilast, filling a void in seborrheic dermatitis (SD) treatment. These experts highlight patient-reported response to this novel treatment and their own experiences in clinical trials with this drug.

Navigating SD Challenges: Expert Treatment Strategies

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 27th 2023

Dermatologists discuss diverse patient presentations and effective treatments for seborrheic dermatitis (SD), addressing over-the-counter product challenges, immune signatures, and treatment nuances in pediatric care.

Prior Treatment Options and Outcomes for SD

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 16th 2023

Experts shed light on the challenges of seborrheic dermatitis treatment, emphasizing the historical lack of treatment options and importance of patient education.

The Impact of Seborrheic Dermatitis

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 16th 2023

Dermatologists discuss the profound impact of seborrheic dermatitis on an individual’s quality of life, discussing self-reported effects on self-esteem, social interactions, and career trajectories.

Neal Bhatia, MD, and Shawn Kwatra, MD, sit at a table discussing seborrheic dermatitis.

Seborrheic Dermatitis vs. Other Skin Conditions

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 9th 2023

Dermatologists discuss differentiating seborrheic dermatitis from conditions like psoriasis, eczema, and lupus, highlighting similarities and differences with other skin conditions.

James Song, MD, and Adelaide Hebert, MD, sit at a table discussing seborrheic dermatitis.

Navigating Seborrheic Dermatitis (SD): An Overview With Expert Perspectives

Linda Stein Gold, MD;Neal Bhatia, MD;Shawn Kwatra, MD;James Song, MD;Adelaide A. Hebert, MD

November 9th 2023

Dermatologists introduce this series providing and overview of seborrheic dermatitis (SD), highlighting common causes, contributing factors, and the various ways it may present in different patient populations.